Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Edward W. Greeno"'
Autor:
Marie K. Kirby, Ryne C. Ramaker, Jason Gertz, Nicholas S. Davis, Bobbi E. Johnston, Patsy G. Oliver, Katherine C. Sexton, Edward W. Greeno, John D. Christein, Martin J. Heslin, James A. Posey, William E. Grizzle, Selwyn M. Vickers, Donald J. Buchsbaum, Sara J. Cooper, Richard M. Myers
Publikováno v:
Molecular Oncology, Vol 10, Iss 8, Pp 1169-1182 (2016)
Background Pancreatic adenocarcinoma patients have low survival rates due to late‐stage diagnosis and high rates of cancer recurrence even after surgical resection. It is important to understand the molecular characteristics associated with surviva
Externí odkaz:
https://doaj.org/article/18b28309935b4450822c1557f59a1f5b
Autor:
Daniel A. Saltzman, Lance B. Augustin, Thomas J. Gniadek, Gerald Batist, Edward W Greeno, Arnold S. Leonard, Janet L. Schottel
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Salmonella has been shown to preferentially colonize solid tumors. It is known that toxicity limits the systemic administration of immunomodulatory cytokines that have a significant anticancer effect. Therefore, we tested a unique cancer treatment st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd53458e70f3ad4603e88afa628772a4
https://doi.org/10.1097/cji.0000000000000325
https://doi.org/10.1097/cji.0000000000000325
Autor:
Herbert Hurwitz, Vaibhav Sahai, Chris Verslype, Jason Clark, Johanna C. Bendell, Ashwin Reddy Sama, Eric Van Cutsem, Manuel Hidalgo, Edward W Greeno, Eileen M. O'Reilly, Chung Pin Li, Kenneth H. Yu, Christopher James Walker, Fitzroy Dawkins, Teresa Macarulla, Marcelo Garrido Salvo
Publikováno v:
Investigational New Drugs. 36:683-695
Background Ruxolitinib, a Janus kinase 1 (JAK1)/JAK2 inhibitor, plus capecitabine improved overall survival (OS) vs capecitabine in a subgroup analysis of patients with metastatic pancreatic cancer and systemic inflammation (C-reactive protein [CRP]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4efb9dd95fab56ab09c97a08030248f
https://doi.org/10.1007/s10637-018-0580-2
https://doi.org/10.1007/s10637-018-0580-2
Autor:
Katherine C. Sexton, Sara J. Cooper, Martin J. Heslin, Nicholas S. Davis, Donald J. Buchsbaum, Ryne C. Ramaker, James Posey, Edward W Greeno, John D. Christein, Patsy G. Oliver, Selwyn M. Vickers, Jason Gertz, William E. Grizzle, Marie K. Kirby, Bobbi E Johnston, Richard M. Myers
Publikováno v:
Molecular Oncology. 10:1169-1182
Background Pancreatic adenocarcinoma patients have low survival rates due to late-stage diagnosis and high rates of cancer recurrence even after surgical resection. It is important to understand the molecular characteristics associated with survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c7abd884206b5974031446224c9c44
https://doi.org/10.1016/j.molonc.2016.05.004
https://doi.org/10.1016/j.molonc.2016.05.004
Publikováno v:
Journal of Clinical Oncology. 38:76-76
76 Background: The differences in colorectal cancer (CRC) treatment between infusion and oral chemotherapy have challenged clinical teams to maintain clinical quality and patient communications with self-administered therapies. The complexity of many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff8b86a7606e6d385eeb227e1ff7a793
https://doi.org/10.1200/jco.2020.38.4_suppl.76
https://doi.org/10.1200/jco.2020.38.4_suppl.76
Autor:
Martin E. Fernandez-Zapico, Eriko Kawakami, Edward W Greeno, Robert J. Schumacher, Zuzan Cayci, Andrew J. Taylor, John C. Morris, Julia Davydova, Lisa Koodie, Kari Jacobsen
Publikováno v:
Cancer Research. 78:5925-5925
Recently, the use of oncolytic viruses encoding the sodium-iodide symporter (NIS) has become an attractive approach to achieve radionuclide imaging of cancer. However, the potential of virus-induced NIS expression to facilitate therapy with radioacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57a57df56f9d060fa586a3f72ab1de26
https://doi.org/10.1158/1538-7445.am2018-5925
https://doi.org/10.1158/1538-7445.am2018-5925
Autor:
Todd M Tuttle, Eric H. Jensen, Edward W Greeno, Leonard Armstrong, Selwyn M. Vickers, Chung K Lee, Timothy D. Sielaff
Publikováno v:
HPB. 16(2):131-139
Objectives: Neoadjuvant chemoradiotherapy (CRT) is a viable treatment strategy for patients with pancreatic cancer. This study was conducted to evaluate the Virginia Mason Protocol (5-fluorouracil, cisplatin, interferon-α and radiation) given in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caddf6e9a6c63e3dfa97747a8c68782f
Publikováno v:
Journal of Clinical Oncology. 37:e15118-e15118
e15118 Background: Oral therapies in colorectal cancer (CRC) introduce unique complexities in care. Understanding adherence in patients using capecitabine can be challenging. The Discover Program, a novel digital medicine program (DMP), was integrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb9d6917930bd757cc66d9ff2c1a33d6
https://doi.org/10.1200/jco.2019.37.15_suppl.e15118
https://doi.org/10.1200/jco.2019.37.15_suppl.e15118
Autor:
James Fisher, Arkadiusz Z. Dudek, Mark N. Kirstein, Brent W. Williams, Vadim J. Gurvich, Jatinder K. Lamba, Robert A. Kratzke, Edward W Greeno, Richard C. Brundage, Keith M. Skubitz, Amit Khatri, Lev G Lis
Publikováno v:
British Journal of Cancer
Background: Gemcitabine is used for the treatment of several solid tumours and exhibits high inter-individual pharmacokinetic variability. In this study, we explore possible predictive covariates on drug and metabolite disposition. Methods: Forty pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c784c8332ae81e7cbb26c446f17dc7fa
http://europepmc.org/articles/PMC3899768
http://europepmc.org/articles/PMC3899768
Autor:
Mace L. Rothenberg, Edward W Greeno, Eileen M. O'Reilly, Lalan S. Wilfong, Paul A. Decker, Mitchell C. Posner, Ross A. Abrams, Vincent J. Picozzi, W. Traverso, R. C. Martin, Peter W.T. Pisters
Publikováno v:
Annals of Oncology. 22:348-354
Background: The American College of Surgeons Oncology Group sought to confirm the efficacy of a novel interferon-based chemoradiation regimen in a multicenter phase II trial. Patients and methods: Patients with resected (R0/R1) adenocarcinoma of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36f3d4d84dfcc6f404a76bea76b7ce7
https://doi.org/10.1093/annonc/mdq384
https://doi.org/10.1093/annonc/mdq384